Concurrent treatment of aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome with immunosuppressive therapy and eculizumab: a UK experience

• Morag Griffin,
• Austin Kulasekararaj,
• Sheyans Gandhi,
• Talha Munir,
• Stephen Richards,
• Louise Arnold,
• Nana Benson-Quarm,
• Nicola Copeland,
• Isabel Duggins,
• Kathryn Riley,
• Peter Hillmen,
• Judith Marsh,
• Anita Hill

Affiliations

Morag Griffin

Hematology department, St James University Hospital, Leeds, London, UK

Austin Kulasekararaj

Hematology department, King’s college University Hospital, London, UK

Sheyans Gandhi

Hematology department, King’s college University Hospital, London, UK

Talha Munir

Hematology department, St James University Hospital, Leeds, London, UK

Stephen Richards

Hematology department, St James University Hospital, Leeds, London, UK

Louise Arnold

Hematology department, St James University Hospital, Leeds, London, UK

Nana Benson-Quarm

Hematology department, King’s college University Hospital, London, UK

Nicola Copeland

Hematology department, St James University Hospital, Leeds, London, UK

Isabel Duggins

Hematology department, King’s college University Hospital, London, UK

Kathryn Riley

Hematology department, St James University Hospital, Leeds, London, UK

Peter Hillmen

Hematology department, St James University Hospital, Leeds, London, UK

Judith Marsh

Hematology department, King’s college University Hospital, London, UK

Anita Hill

Hematology department, St James University Hospital, Leeds, London, UK